{"id":69875,"date":"2016-04-22T14:00:49","date_gmt":"2016-04-22T14:00:49","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=116bcef8d9076e63f014bd78fa779a28"},"modified":"2016-04-22T14:00:49","modified_gmt":"2016-04-22T14:00:49","slug":"press-release-cma-continues-its-mission-to-remove-unnecessary-remedies","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=69875","title":{"rendered":"Press release: CMA continues its mission to remove unnecessary remedies"},"content":{"rendered":"
\n

In March, the Competition and Markets Authority (CMA<\/abbr>) completed its review<\/a> of 71 old structural merger remedies given by companies prior to 1 January 2005. As a result, 51 of these remedies were removed by the CMA<\/abbr>.<\/p>\n

The CMA<\/abbr> has also completed 2 larger reviews of behavioural remedies this week, with its final decision to remove FirstGroup plc bus undertakings<\/a> on 20 April, and earlier today, the final decision to vary the undertakings given by Centrica<\/a>, following the Rough gas storage review.<\/p>\n

Ahead of its next reviews, which will start in the summer, the CMA<\/abbr> has identified a further 38, mostly behavioural merger remedies that are more than 10 years old. It is now inviting comments<\/a> on which of these it should prioritise in the forthcoming reviews.<\/p>\n

This exercise forms part of a wider programme of work on remedy reviews, initially set out in the CMA<\/abbr>\u2019s 2015\/16 annual plan<\/a>, with the aim of reducing burdens on business by assessing whether past merger and market remedies should be removed. The 2016\/17 annual plan<\/a> restates this aim and pledges to build on the work carried out during the last year.<\/p>\n

Adam Land, the CMA<\/abbr>\u2019s Senior Director of Remedies, Business and Financial Analysis, said:<\/p>\n

\n

We\u2019ve done some valuable work clearing out unnecessary remedies over the past year. This work reduces ongoing burdens on business and enables the CMA<\/abbr> to focus its resources on enforcing those remedies that still matter. We\u2019re looking to continue that momentum and have identified another batch of older remedies that look like suitable candidates for review. However, before we kick things off we want to hear from interested parties to ensure that we select the right cases.<\/p>\n<\/blockquote>\n

Those wishing to comment on the merger remedies identified, should write, supported with relevant evidence where possible, by 5pm on 20 May 2016 to remedies.reviews@cma.gsi.gov.uk<\/a> or:<\/p>\n

\n
\n

Merger Remedy Reviews
\n
Competition and Markets Authority
\n
7th Floor North
\n
Victoria House
\n
37 Southampton Row
\n
London WC1B 4AD
\n\n<\/p>\n<\/div>\n<\/div>\n

Full details on the CMA<\/abbr>\u2019s remedies review programme<\/a> so far are available on the CMA<\/abbr> website.<\/p>\n

Notes for editors<\/h4>\n
    \n
  1. The CMA<\/abbr> is the UK\u2019s primary competition and consumer authority. It is an independent non-ministerial government department with responsibility for carrying out investigations into mergers, markets and the regulated industries and enforcing competition and consumer law. <\/li>\n
  2. The CMA<\/abbr> has a statutory duty under the Fair Trading Act 1973 and the Enterprise Act 2002 to keep undertakings and orders under review. From time to time, the CMA<\/abbr> must consider whether, by reason of any change of circumstances: undertakings are no longer appropriate and need to be varied, superseded or released; or an order is no longer appropriate and needs to be varied or revoked. Responsibility for deciding on variation or termination of orders lies with the CMA<\/abbr> except for a small number of older remedies where decisions are for the Secretary of State following advice from the CMA<\/abbr>.<\/li>\n
  3. Enquiries should be directed to Rory Taylor (rory.taylor@cma.gsi.gov.uk<\/a>, 020 3738 6798)<\/li>\n
  4. For more information on the CMA<\/abbr> see our homepage<\/a> or follow us on Twitter @CMAgovuk<\/a>, Flickr<\/a> and LinkedIn<\/a>.<\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    The CMA is poised to launch another series of reviews of merger remedies in its drive to ensure they do not stay in place longer than needed.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/69875"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69875"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/69875\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}